Literature DB >> 19915601

Can we afford it?: ethical consideration of expensive drug treatment for neonates and infants.

R Zlotnik Shaul1, D Vitale.   

Abstract

When considering expensive drug treatment for neonates and infants, how should we decide what we can and cannot afford? Accountably allocating health-care resources can be achieved using a framework that reflects the values a society considers so reflective of the collective will that they have been formally entrenched in law. The values and procedural mechanisms entrenched in the Canadian Charter of Rights and Freedoms are particularly helpful for those faced with these difficult spending decisions.

Entities:  

Mesh:

Year:  2009        PMID: 19915601     DOI: 10.1038/clpt.2009.211

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  The Potential Value of the U.N. Convention on the Rights of the Child in Pediatric Bioethics Settings.

Authors:  Michael Da Silva; Cheryl D Lew; Laura Lundy; Kellie R Lang; Irene Melamed; Randi Zlotnik Shaul
Journal:  Perspect Biol Med       Date:  2016       Impact factor: 1.416

2.  Enzyme replacement therapy in perinatal hypophosphatasia: Case report of a negative outcome and lessons for clinical practice.

Authors:  Gregory Costain; Aideen M Moore; Lauren Munroe; Alison Williams; Randi Zlotnik Shaul; Cheryl Rockman-Greenberg; Martin Offringa; Peter Kannu
Journal:  Mol Genet Metab Rep       Date:  2017-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.